Basal Cell Carcinoma (BCC) Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: BCC - Basal Cell Carcinoma / Basal Cell Carcinomas / Basal Cell Carcinoma / Carcinoma basal cell / Basalioma / Basal cell epithelioma / Rodent ulcer / Basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma of skin (disorder) / Carcinoma, Basal Cell

DBCOND0040396 (Basal Cell Carcinoma (BCC))Recruiting2 IdentifierTitlePurposeDrugs
NCT03521830Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell CarcinomaTreatment